Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?

Urology

Volumn 76, Issue 3, 2010, Pages 608-609

  Lane, Brian R ^a,b   Fergany, Amr F ^c   Linehan, W Marston ^d   Bratslavsky, Gennady ^d  

^a SPECTRUM HEALTH   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; FEASIBILITY STUDY; HUMAN; KIDNEY CANCER; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; KIDNEY NEOPLASMS; NEPHRECTOMY; PATHOLOGY; PROCEDURES;

HUMANS; KIDNEY NEOPLASMS; NEPHRECTOMY;

EID: 77956535588     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.04.041     Document Type: Article

References (23)

1. C.T. Lee, J. Katz, and W. Shi Surgical management of renal tumors 4 cm or less in a contemporary cohort J Urol. 163 2000 730 736
2. W.K. Lau, M.L. Blute, and A.L. Weaver Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney Mayo Clin Proc. 75 2000 1236 1242
3. J. McKiernan, R. Simmons, and J. Katz Natural history of chronic renal insufficiency after partial and radical nephrectomy Urology 59 2002 816 820
4. R.H. Thompson, S.A. Boorjian, and C.M. Lohse Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy J Urol. 179 2008 468 473
5. W.C. Huang, E.B. Elkin, and A.S. Levey Partial nephrectomy versus radical nephrectomy in patients with small renal tumorsis there a difference in mortality and cardiovascular outcomes? J Urol. 181 2009 55 62
6. C.J. Weight, B.T. Larson, and A.F. Fergany Nephrectomy-induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses J Urol. 183 2010 1317 1323
7. R.H. Thompson, S. Siddiqui, and C.M. Lohse Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors J Urol. 182 2009 2601 2606
8. C.J. Weight, B.T. Larson, and B.R. Lane Elective partial nephrectomy in patients with clinical T1b renal tumors offers equivalent cancer control, improved renal function outcomes and possibly improved overall survival J Urol. 183 2010 1317 1323
9. F. Becker, S. Siemer, and M. Hack Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm Eur Urol. 49 2006 1058 1064
10. M. Carini, A. Minervini, and A. Lapini Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival J Urol. 175 2006 2022 2026
11. G.N. Gupta, J. Peterson, and K.N. Thakore Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm J Urol. 2010 In press
12. Fadahunsi AT, Sanford T, Linehan WM, et al. Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors from a single renal unit (abstract) presented at: American Urological Association Annual Meeting; May 29-June 3, 2010; San Francisco, CA.
13. A. Kutikov, and R. Uzzo The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth J Urol. 182 2009 844 853
14. M.N. Simmons, C.B. Ching, and M.K. Samplaski Kidney tumor location measurement using the C index method J Urol. 183 2010 1708 1713
15. C. Jeldres, A. Pantuck, and A. Belldegrun Nephron-sparing surgery vs. radical nephrectomy in patients with renal cell carcinoma >7 cm with no evidence of nodal or distant metastasis (abstract) J Urol. 179 2008 417 418
16. R.H. Breau, P.L. Crispen, and R.E. Jimenez Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy J Urol. 183 2010 903 908
17. Weight CJ, Larson B, Lieser G, et al. Pathological upstaging and survival in patients with pT2/T3 renal tumors treated by either partial nephrectomy or radical nephrectomy (abstract). Presented at: American Society of Clinical Oncology Genitourinary Cancers Symposium, March 5-7, 2010, San Francisco, CA. Available online at http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview= abst-detail-view&confID=73&abstractID=30266.
18. Woldu SL, Barlow LJ, Patel T, et al. Single institutional experience with nephron-sparing surgery for pathologic stage T3bNxM0 renal cell carcinoma confined to the renal vein. Urology. Epub 2010 Feb 15.
19. Kolla SB, Ercole C, Spiess PE, et al. Nephron-sparing surgery for pathological stage T3(b) renal cell carcinoma confined to the renal vein. BJU Int. Epub 2010 Mar 4.
20. A.S. Go, A.M. Chertow, and D. Fan Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization N Engl J Med. 351 2004 1296 1305
21. B.R. Lane, E.D. Poggio, and B.R. Herts Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care J Urol. 182 2009 435 443
22. B.I. Rini New strategies in kidney cancer: therapeutic advances through understanding the molecular basis of response and resistance Clin Cancer Res. 16 2010 1348 1354
23. A.C. Novick Renal-sparing surgery for renal cell carcinoma Urol Clin North Am. 20 1993 277 282